GlassScriptPhysician profile
John M Bete
NPI 1457577652
$4,069.21
in general payments reported to CMS, 2019-2025
42 companies · $721 in 2025
The $721 reported for 2025 was more than what 84% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $750 · 2020: $362 · 2021: $787 · 2022: $642 · 2023: $307 · 2024: $499 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,527.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $429.59 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Amgen INC. | $391.31 | 2019-2022 | |
| Boston Scientific Corporation | $391.12 | 2020-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Scilex Pharmaceuticals INC. | $360.30 | 2019-2024 | Ztlido |
| Vertex Pharmaceuticals Incorporated | $244.94 | 2024-2025 | |
| Abbvie INC. | $217.43 | 2021-2025 | |
| Biodelivery Sciences International, INC. | $188.59 | 2020-2021 | |
| Painteq LLC | $176.92 | 2021-2024 | Painteq |
| Pacira Therapeutics, INC. | $138.87 | 2019-2020 | |
| Abbott Laboratories | $129.78 | 2019-2025 | Eterna |
| Pfizer INC. | $106.99 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $101.32 | 2022 | |
| Novartis Pharmaceuticals Corporation | $90.24 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $86.64 | 2021 | |
| Almatica Pharma LLC | $83.72 | 2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bete listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.